News | Artificial Intelligence | December 14, 2021

Artificial Intelligence in Medicine Review Course through ABAIM allows students to obtain their educational certification

Guerbet LLC, the U.S. affiliate of Guerbet, a global leader in medical imaging, announced that it will be providing 100 academic educational scholarships to the American Board of Artificial Intelligence in Medicine (ABAIM) to fund participation in its AI in Medicine Review Course

December 14, 2021 — Guerbet LLC, the U.S. affiliate of Guerbet, a global leader in medical imaging, announced that it will be providing 100 academic educational scholarships to the American Board of Artificial Intelligence in Medicine (ABAIM) to fund participation in its AI in Medicine Review Course.

Guerbet dedicates 10% of its annual revenue to continual innovation, expanding education as well as research and development surrounding artificial intelligence in the medical field. As a founding sponsor of ABAIM, Guerbet’s recent sponsorship will be utilized to develop scholarships and offer tuition free access to the course for 100 students. ABAIM targets data scientists, nurses and clinicians, as well as high school and college students interested in advancing the newly-developed field of artificial intelligence and its applications in all fields of medicine.

“We are proud to be the founding sponsor of the American Board of Artificial Intelligence in Medicine,” said Tom McLaughlin, vice president North American at Guerbet. “We feel strongly that technology in health care improves patient outcomes and provides medical professionals with additional tools and resources to further advance medicine in their respective fields. ABAIM’s course is an excellent opportunity for students and clinicians to gain a functional knowledge of AI and its healthcare applications.”

Guerbet and ABAIM believe technology and artificial intelligence will enhance the capabilities of medical professionals and allow for more time to be focused on patient interaction and care. The AI in Medicine Review Course is a comprehensive, two-day course designed by a team of clinician-data scientists with an AI focus. The aim of the review course is to empower and educate students, clinicians and industry executives in their pursuit of integrating artificial intelligence into medicine.

“We have found a fantastic partner in Guerbet,” said Orest Boyko, M.D., ABAIM co-chair. “They bring a great deal of additional knowledge and expertise on AI in the Medical field.” ABAIM Chair Anthony Chang, M.D., added, “Their sponsorship has allowed us to provide tuition-free access to our review course for hundreds of students and medical professionals and to imbue a new generation with the knowledge required to build an AI-enabled healthcare system. We are excited to see this partnership grow.”

In addition to the review course, the ABAIM also offers an educational certification to students and healthcare professionals who meet the standards of competency in medical AI. In the future, the ABAIM plans to also offer board certification. Both the review course and certification process are open to all stakeholders, including students.

The ABAIM, in partnership with Guerbet, is eager to develop the next generation of medical professionals by engaging with high school and college students, as well as current healthcare professionals. By empowering the healthcare community with a greater understanding of AI technology, ABAIM and Guerbet hope to better harness the massive potential of AI, leading to a more effective healthcare system and better outcomes for patients everywhere.

For more information: www.guerbet-us.com


Related Content

News | Radiology Imaging

Feb. 12, 2026 — Siemens Healthineers and Mayo Clinic are expanding their strategic collaboration to enhance patient care ...

Time February 13, 2026
arrow
Feature | Cardiac Imaging | Kyle Hardner

Advances in coronary CT angiography (CCTA) have reached the point where image quality and AI capabilities are creating ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Lung Imaging

Feb. 3, 2026 — RevealDx, a leader in the characterization of lung nodules, recently announced FDA clearance of RevealAI ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
News | FDA

Jan. 29, 2026 — GE HealthCare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for MIM ...

Time February 03, 2026
arrow
News | Radiology Imaging

Jan.26, 2026 — SimonMed Imaging has unveiled an updated brand and the launch of SimonMed Longevity, a new division ...

Time January 27, 2026
arrow
News | Point-of-Care Ultrasound (POCUS)

Jan. 22, 2026 — Qure.ai has received a grant from the Gates Foundation to develop a large open-source multi-modal ...

Time January 23, 2026
arrow
News | Remanufactured Refurbished Equipment

Jan. 11, 2026 — The Global Refurbished Medical Imaging Equipment Market Size is projected to grow at a CAGR of 15.07% ...

Time January 23, 2026
arrow
News | RSNA

Jan. 22, 2026 — The nomination deadline for the 2026 RSNA Rising Star Award is approaching. The Rising Star Award is ...

Time January 22, 2026
arrow
Subscribe Now